Selvita Extends Collaboration with Chiesi Farmaceutici
News Jan 13, 2014
Selvita has extended its chemistry research collaboration with Chiesi Farmaceutici from Italy.
“We are very proud to be working for such renowned and innovative company as Chiesi. Chiesi projects always involve novel, challenging chemistry and they let us demonstrate the full potential of Selvita’s chemistry team, our broad knowledge, experience and skills.” said Dr Miroslawa Zydron, Director of Contract Chemistry Department at Selvita.
The collaboration between Chiesi and Selvita started with fee-for-service chemical synthesis in 2011. After the successful completion of several projects, it evolved into FTE-based collaboration in 2012-2013.
The joint projects support Chiesi proprietary drug discovery and development pipeline, which is focused on respiratory, cardiovascular and special care disorders.
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE